Latest Top 20 Read Articles

1. Letter to the Editor

G Smith, JA Smith and DA Brindley

The Falsified Medicines Directive: How to secure your supply chain

Journal of Generic Medicines: The Business Journal for the Generic Medicines Sector September–December 2014 11: 169–172, first published on June 1, 2015, doi:10.1177/1741134315588986

2. Editorial

Brian W Tempest

Journal of Generic Medicines: The Business Journal for the Generic Medicines Sector September–December 2014 11: 97, doi:10.1177/1741134315592208

3. Editorial

Maria Fabiana Jorge

Would the Trans-Pacific Partnership Agreement undermine Japan’s efforts to control health care expenditures?

Journal of Generic Medicines: The Business Journal for the Generic Medicines Sector September–December 2013 10: 147, first published on November 19, 2014, doi:10.1177/1741134314558353

4. Original Paper

Steven Simoens and Sandra De Coster

Sustaining Generic Medicines Markets in Europe

Journal of Generic Medicines: The Business Journal for the Generic Medicines Sector

July 2006 3: 257–268, doi:10.1057/palgrave.jgm.4940128

5. Letter to the Editor

Alessandro Monaco, Federica Mammarella, Agnese Cangini, Roberto Marini, Alessandra Marengoni, Pierluigi Russo, Sergio Pecorelli and Luca Pani

Generic and biosilimilar medicines use and expenditure: A report from the National Observatory on the Use of Medicines (OsMed) of the Italian Medicines Agency (AIFA)

Journal of Generic Medicines: The Business Journal for the Generic Medicines Sector 1741134315618535, first published on November 26, 2015, doi:10.1177/1741134315618535

6. Editorial

Brian W Tempest

Journal of Generic Medicines: The Business Journal for the Generic Medicines Sector March 2015 12: 3, doi:10.1177/1741134315619286

7. Original Paper

Mohamed Azmi Hassali, Kah Hay Yuen, Mohamed Izham Mohamed Ibrahim, Jia Woei Wong, Bee Hong Ng and David Sue San Ho

Malaysian pharmaceutical industry: Opportunities and challenges Journal of Generic Medicines: The Business Journal for the Generic Medicines Sector May 2009 6: 246–252, doi:10.1057/jgm.2009.12

8. Original Paper

Don Williams

Creating brand identity for generic products

Journal of Generic Medicines: The Business Journal for the Generic Medicines Sector July 2004 1: 347–352, doi:10.1057/palgrave.jgm.4940040

9. Australia's Pharmaceutical Patent Review

Wayne Condon

Australia's Pharmaceutical Patent Review: A brief update

Journal of Generic Medicines: The Business Journal for the Generic Medicines Sector March 2013 10: 65–68, doi:10.1177/1741134313483750

10. EU Legal and Regulatory Update

Richard Milchior and Séverine Charbonnel

Pharmaceutical; Trademark; Patents; News

Journal of Generic Medicines: The Business Journal for the Generic Medicines Sector September–December 2014 11: 150–156, first published on April 7, 2015, doi:10.1177/1741134315579526

11. Original Paper

Joseph E Stiglitz and Arjun Jayadev

Medicine for tomorrow: Some alternative proposals to promote socially beneficial research and development in pharmaceuticals

Journal of Generic Medicines: The Business Journal for the Generic Medicines Sector July 2010 7: 217–226, doi:10.1057/jgm.2010.21

12. Original Paper

Nabil Abdo Al-Gedadi and Mohamed Azmi Hassali

Pharmacists' views on generic medicines: A review of the literature

Journal of Generic Medicines: The Business Journal for the Generic Medicines Sector April 2008 5: 209–218, doi:10.1057/jgm.2008.7

13. Original Paper

Mohamed Azmi Hassali, Fahad Saleem, Atisha Abdul Hanif, Catherine Lim Tze Yinn, Leong Pui Chee, Teoh Tsyr Fen, Chua Gin Nie and Tahir Mehmood Khan

A survey assessing knowledge and perception of prescribers towards generic medicines in Hospital Seberang Jaya

Journal of Generic Medicines: The Business Journal for the Generic Medicines Sector March–June 2014 11: 4–10, first published onNovember 20, 2014, doi:10.1177/1741134314559789

14. Original Paper

Mike Hutchins

Extending the monopoly – How ‘secondary patents’ can be used to delay or prevent generic competition upon expiry of the basic product patent

Journal of Generic Medicines: The Business Journal for the Generic Medicines Sector October 2003 1: 57–71,doi:10.1057/palgrave.jgm.4940018

15. Original Paper

Mazen Tantash

Middle East generics: Challenges & opportunities Journal of Generic Medicines: The Business Journal for the Generic Medicines Sector March 2012 9: 13–20, doi:10.1177/1741134312439974

16. Original Paper

Rossen Kazakov

Pricing and reimbursement policies in New EU accession countries

Journal of Generic Medicines: The Business Journal for the Generic Medicines Sector July 2007 4: 249–258,doi:10.1057/palgrave.jgm.4950068

17. Original Paper

Shivam Vashisth, Govind Singh and Arun Nanda

A comparative study of regulatory trends of pharmaceuticals in Brazil, Russia, India and China (BRIC) countries

Journal of Generic Medicines: The Business Journal for the Generic Medicines Sector September 2012 9: 128–143, doi:10.1177/1741134312459187

18. Original Paper

Yusi Anggriani, Mohamed Izham M Ibrahim, Sri Suryawati and Asrul A Shafie

The impact of Indonesian generic medicine pricing policy on medicine prices

Journal of Generic Medicines: The Business Journal for the Generic Medicines Sector September–December 2013 10: 219–229, first published on October 9, 2014, doi:10.1177/1741134314553605

19. Original Paper

Osamu Saigusa

Japan's healthcare system and pharmaceutical industry

Journal of Generic Medicines: The Business Journal for the Generic Medicines Sector October 2006 4: 23–29, doi:10.1057/palgrave.jgm.4950039

20. Original Paper

Susan M Rosencrance and Geoffrey K Wu

Advancing pharmaceutical quality oversight during the lifecycle of generic drug products

Journal of Generic Medicines: The Business Journal for the Generic Medicines Sector March 2015 12: 26–33, first published on September 30, 2015, doi:10.1177/1741134315608909